Cantor Fitzgerald’s Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PNTM.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-116,836
Closed -$20.1K 744
2023
Q1
$20.1K Hold
116,836
﹤0.01% 607
2022
Q4
$9K Hold
116,836
﹤0.01% 661
2022
Q3
$7K Hold
116,836
﹤0.01% 732
2022
Q2
$15K Sell
116,836
-100
-0.1% -$22 ﹤0.01% 762
2022
Q1
$38K Buy
116,936
+41,936
+56% +$19.9K ﹤0.01% 346
2021
Q4
$67K Buy
+75,000
New +$60.3K ﹤0.01% 337

Cantor Fitzgerald's PNTM.WS Position: Q2 2023 in Review

Cantor Fitzgerald sold out of Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PNTM.WS) in Q2 2023, closing a stake of 116,836 shares — an estimated $20.1K sold.

Cantor Fitzgerald first reported a position in PNTM.WS in Q4 2021 and held it in 6 quarters. The position peaked at $67K in Q4 2021. 0 funds tracked by Wall St. Rank hold PNTM.WS as of Q2 2023.

  • Cantor Fitzgerald reported no remaining Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 116,836 Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $20.1K.
  • Cantor Fitzgerald first reported a position in Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 6 quarters.
  • Cantor Fitzgerald's Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $67K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on Cantor Fitzgerald's 13F filing for Q2 2023, filed 14 Aug 2023.